Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Autoimmunity and thyrotropin level in developing thyroid malignancy.

Medenica S, Radojevic N, Stojkovic M, Nedeljkovic-Beleslin B, Savic S, Ciric J, Trbojevic B, Zarkovic M.

Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2824-9.

2.

Anti-thyroid antibodies as a predictor of thyroid cancer.

Wong SL, Grodski S, Yeung MJ, Serpell JW.

ANZ J Surg. 2015 Nov;85(11):849-53. doi: 10.1111/ans.12453. Epub 2013 Dec 3.

PMID:
24299506
3.

Correlation of thyroid fine-needle aspiration with final histopathology: a case series.

Gürkan Dumlu E, Kiyak G, Bozkurt B, Tokaç M, Polat B, Cakir B, Güler G, Kiliç M.

Minerva Chir. 2013 Apr;68(2):191-7.

PMID:
23612233
4.

Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence.

Gabalec F, Srbova L, Nova M, Hovorkova E, Hornychova H, Jakubikova I, Ryska A, Cap J.

Endokrynol Pol. 2016;67(1):48-53. doi: 10.5603/EP.a2016.0022.

5.

Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A.

Ann Intern Med. 2003 Sep 2;139(5 Pt 1):346-51.

PMID:
12965943
6.

Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.

Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan Z, Zhang J.

Endocrine. 2014 Aug;46(3):554-60. doi: 10.1007/s12020-013-0121-x. Epub 2013 Dec 14.

PMID:
24338678
7.

Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.

Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY.

Thyroid. 2010 Aug;20(8):885-91. doi: 10.1089/thy.2009.0384.

PMID:
20465529
8.

Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.

Zimny M, Selkinski I, Blasius S, Rink T, Schroth HJ, Grünwald F.

Nuklearmedizin. 2012;51(4):119-24. doi: 10.3413/Nukmed-0456-12-01. Epub 2012 Apr 12.

PMID:
22526481
9.

Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.

Boi F, Minerba L, Lai ML, Marziani B, Figus B, Spanu F, Borghero A, Mariotti S.

J Endocrinol Invest. 2013 May;36(5):313-20. doi: 10.3275/8579. Epub 2012 Aug 29.

PMID:
22931861
10.

Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.

Baser H, Topaloglu O, Tam AA, Evranos B, Alkan A, Sungu N, Dumlu EG, Ersoy R, Cakir B.

Endocrine. 2016 Aug;53(2):520-9. doi: 10.1007/s12020-016-0919-4. Epub 2016 Mar 14.

PMID:
26972701
11.

Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology.

Grani G, Calvanese A, Carbotta G, D'Alessandri M, Nesca A, Bianchini M, Del Sordo M, Vitale M, Fumarola A.

Head Neck. 2015 Feb;37(2):260-4. doi: 10.1002/hed.23587. Epub 2014 Apr 3.

PMID:
24375752
12.

Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?

Yazici P, Mihmanli M, Bozkurt E, Ozturk FY, Uludag M.

Hormones (Athens). 2016 Apr;15(2):256-263. doi: 10.14310/horm.2002.1677.

13.

Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.

Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T.

Ann Surg Oncol. 2014 Aug;21(8):2725-32. doi: 10.1245/s10434-014-3593-x. Epub 2014 Mar 5.

PMID:
24595799
14.

The value of ultrasonography in predicting autoimmune thyroid disease.

Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H.

Thyroid. 2000 Mar;10(3):251-9.

PMID:
10779140
15.

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.

Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti P, Grasso L, Elisei R, Pinchera A, Vitti P.

Endocr Relat Cancer. 2009 Dec;16(4):1251-60. doi: 10.1677/ERC-09-0036. Epub 2009 Jun 15.

PMID:
19528244
16.

Role of FNA in the medical management of minimally enlarged thyroid.

Kini U, Buch A, Bantwal G.

Diagn Cytopathol. 2006 Mar;34(3):196-200.

PMID:
16470863
17.

Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.

Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA.

J Clin Endocrinol Metab. 2006 Nov;91(11):4295-301. Epub 2006 Jul 25.

PMID:
16868053
18.

[Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].

Rink T, Dembowski W, Schroth HJ, Klinger K.

Nuklearmedizin. 2000 Aug;39(5):133-8. German.

PMID:
10984889
19.

Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.

Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P, Pinchera A, Vitti P.

Eur J Endocrinol. 2010 Apr;162(4):763-70. doi: 10.1530/EJE-09-0895. Epub 2010 Jan 18.

PMID:
20083557
20.

[Thyroid autoantibodies].

Le NH, Ballieux BE, Corssmit EP.

Ned Tijdschr Geneeskd. 2015;159:A8802. Dutch.

PMID:
26104003

Supplemental Content

Support Center